Dr Reddy's

Dr. Reddy's to buy Mayne Pharma’s US generics drug list for at least $90M
Dr. Reddy's to buy Mayne Pharma’s US generics drug list for at least $90M
Endpoints
generics
Dr Reddy's
Mayne Pharma
Flag link:
Delpharm acquires injectable drug development center in the Netherlands from Dr Reddy's
Delpharm acquires injectable drug development center in the Netherlands from Dr Reddy's
Biopharma Reporter
Delpharm
CDMOs
drug development
The Netherlands
Dr Reddy's
Flag link:
Dr. Reddy's subsidiary hits the pause button on drug development for psoriasis
Dr. Reddy's subsidiary hits the pause button on drug development for psoriasis
Endpoints
Dr Reddy's
psoriasis
Aurigene
clinical trials
AUR101
Flag link:
Dr. Reddy’s launches extended-release rival to $200M Pfizer drug
Dr. Reddy’s launches extended-release rival to $200M Pfizer drug
Fierce Pharma
Dr Reddy's
Pfizer
overactive bladder
Toviaz
generics
Flag link:
After Big Pharma pulls back in Russia, Dr. Reddy's says business is booming
After Big Pharma pulls back in Russia, Dr. Reddy's says business is booming
Fierce Pharma
Russia
Ukraine
India
Dr Reddy's
Flag link:
India's hesitance to condemn Russia puts the country's pharma industry in compromising position
India's hesitance to condemn Russia puts the country's pharma industry in compromising position
Fierce Pharma
Russia
Ukraine
India
Cipla
Dr Reddy's
Torrent Pharmaceuticals
Sun Pharma
Flag link:
Dr Reddy’s jumps on medical cannabis train, buying Nimbus Health
Dr Reddy’s jumps on medical cannabis train, buying Nimbus Health
Pharmaforum
Dr Reddy's
Nimbus Health
Medical Marijuana
M&A
Flag link:
Dr Reddy's to launch generic COVID-19 Merck drug at about 50 cents a pill
Dr Reddy's to launch generic COVID-19 Merck drug at about 50 cents a pill
Reuters
Dr Reddy's
Merck
generics
COVID-19
molnupiravir
Flag link:
Prestige BioPharma and Dr. Reddy’s partner to sell trastuzumab biosimilar
Prestige BioPharma and Dr. Reddy’s partner to sell trastuzumab biosimilar
Pharmaceutical Business Review
Prestige BioPharma
Dr Reddy's
trastuzumab
biosimilars
Latin American
Asia
Flag link:
Dr. Reddy’s begins pilot of Russia’s Sputnik V vaccine in India
Dr. Reddy’s begins pilot of Russia’s Sputnik V vaccine in India
Pharmaceutical Business Review
Dr Reddy's
vaccines
Sputnik V
Russia
COVID-19
clinical trials
Flag link:
Dr. Reddy’s to acquire select anti-allergy brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan
Dr. Reddy’s to acquire select anti-allergy brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan
Pharmaceutical Business Review
Dr Reddy's
Glenmark
M&A
anti-allergy
Flag link:
Bristol-Myers Squibb Cuts Deal, Delaying Threat to Top-Selling Revlimid
Bristol-Myers Squibb Cuts Deal, Delaying Threat to Top-Selling Revlimid
Motley Fool
Bristol-Myers Squibb
Dr Reddy's
Revlimid
Multiple Myeloma
Flag link:
While Novartis combats generic onslaught in the courts, FDA approves first Gilenya copycats
While Novartis combats generic onslaught in the courts, FDA approves first Gilenya copycats
Endpoints
Novartis
FDA
Gilenya
MS
multiple sclerosis
Mylan
Dr Reddy's
Torrent Pharmaceuticals
Aurobindo
generics
Flag link:
What has Zantac recall cost drugmakers? Dr. Reddy's gives a hint
What has Zantac recall cost drugmakers? Dr. Reddy's gives a hint
Fierce Pharma
Zantac
OTC
product recalls
generics
Dr Reddy's
Flag link:
What's the definition of insanity? Dr. Reddy's knocked by the FDA for the fifth time this year
What's the definition of insanity? Dr. Reddy's knocked by the FDA for the fifth time this year
Fierce Pharma
Dr Reddy's
FDA
drug manufacturing
Flag link:
Dr. Reddy's Copaxone, NuvaRing generics derailed by FDA
Dr. Reddy's Copaxone, NuvaRing generics derailed by FDA
Fierce Pharma
FDA
Dr Reddy's
Copaxone
Teva Pharmaceutical
generics
Merck
Nuvaring
Flag link:
Another day, another Form 483 for a Dr. Reddy's plant
Another day, another Form 483 for a Dr. Reddy's plant
Fierce Pharma
FDA
Dr Reddy's
drug manufacturing
India
Flag link:
Lyrica Patent Expiration Ushers In 9 Generic Competitors
Lyrica Patent Expiration Ushers In 9 Generic Competitors
Xtalks
Pfizer
Lyrica
patents
generics
Alembic Pharmaceuticals
Alkem Laboratories
Amneal
Dr Reddy's
InvaGen
MGN Laboratories
Rising Pharmaceuticals
Sciegen Pharmaceuticals
Teva Pharmaceutical
Flag link:
Indivior loses appeal to block generic Suboxone opioid treatments
Indivior loses appeal to block generic Suboxone opioid treatments
Reuters
Indivior
Dr Reddy's
Alvogen
generics
Suboxone
opioids
Flag link:
Dr. Reddy’s to sell neurology branded products to Upsher-Smith Laboratories
Dr. Reddy’s to sell neurology branded products to Upsher-Smith Laboratories
Pharmaceutical Business Review
Dr Reddy's
M&A
Upsher-Smith
neurology
Flag link:

Pages